Reimbursed Care Access in Mongolia

Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical use outside of approved clinical research. Mongolia is a party to the UN drug control conventions, which form the foundation of its domestic controlled-substances framework and practice of restricting non-medical psychoactive substances. #

Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical use outside of approved clinical research. Mongolia’s drug-control approach follows the international conventions and treats MDMA/related psychostimulants as illicit psychotropic substances. #

There is no publicly available record of esketamine (Spravato) having received regulatory marketing approval or routine clinical/reimbursed use in Mongolia; no Mongolian regulatory database entries or authoritative announcements were identified in open-source searches. Ketamine (the racemate) is routinely used in Mongolian hospitals as a surgical anesthetic, but esketamine as a branded, marketed nasal antidepressant has no documented approval or established reimbursement pathway in Mongolia as of the sources checked. For contrast, ketamine’s routine intraoperative and analgesic use in Mongolian hospitals has been documented in a nationwide anesthesia survey. # #

Ketamine is an established, routinely used anesthetic and analgesic in Mongolian hospitals and surgical centers; a nationwide survey found dissociative ketamine anesthesia and ketamine listed among the most frequently used hypnotics in Mongolian operating theatres, indicating broad institutional medical availability for anesthetic indications. The survey describes ketamine use across public hospitals (including regional hospitals and facilities in Ulaanbaatar), demonstrating it is part of standard perioperative care rather than an experimental reimbursed psychiatric therapy. Specific regulatory oversight for ketamine is exercised under Mongolia’s general controlled-substances and medical practice frameworks (i.e., use limited to licensed medical facilities and personnel), but publicly accessible documentation of any national reimbursement policy for off-label psychiatric ketamine treatment (e.g., for depression) was not identified in open sources. # #

Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical use outside of approved clinical research. Mongolia’s domestic drug-control regime implements the obligations of international psychotropic conventions and does not provide for routine medical/psychiatric access to DMT outside tightly controlled research. #

Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical use outside of approved clinical research. No public evidence of approved therapeutic or reimbursed programs for 5‑MeO‑DMT in Mongolia was identified. #

Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical use outside of approved clinical research. There is no public record of licensed ibogaine clinics or authorized medical programs in Mongolia. #

Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical or religious exemption permitting routine use; plant materials containing scheduled tryptamines would be treated under Mongolia’s controlled-substances framework and international convention obligations. #

Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical use outside of approved clinical research. There is no public evidence of licensed medical or reimbursed mescaline therapy in Mongolia. #

Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical use outside of approved clinical research. Designer phenethylamines (including 2C-series analogues) are encompassed by Mongolia’s enforcement practice tied to the international psychotropic substance controls. #